Finance and markets: business, quotes, gold, energy and releases.
Found 30310 articles
Investors who purchased BitGo Holdings stock following its January 22, 2026, initial public offering are being urged to join a class action lawsuit against the company. The litigation alleges that the digital asset firm misled shareholders regarding its financial health and exposure to market volatility during its public debut.
The Southern California University of Health Sciences is debuting a monthly educational series, Living Well, aimed at translating complex clinical research into accessible guidance for the public. The inaugural installment dissects the physiological toll of chronic stress, moving beyond emotional symptoms to address systemic bodily impacts.
Taiwanese technology group FIC Global has launched a dual-partnership initiative to anchor its manufacturing and supply chain operations within the Johor–Singapore Special Economic Zone. By pairing Malaysian industrial production with Singaporean innovation, the company aims to build a more resilient cross-border model for global high-tech markets.
Investors in the JPMorgan Equity Income Fund (OIEIX) are now under legal scrutiny as the Los Angeles-based firm Schall, Brown & Schwartz LLP probes potential securities law violations. The inquiry centers on whether the fund misled shareholders or withheld critical financial information necessary for informed investment decisions.
PepsiCo APAC has secured a landmark agreement to purchase environmental attribute certificates for 1,000 tonnes of low-carbon ammonia from Envision Energy. By decoupling environmental benefits from physical supply, the deal creates a scalable model to address Scope 3 emissions in agricultural supply chains without disrupting existing logistics.
Investors who held Rackspace Technology, Inc. stock between May 7 and July 8, 2026, are being sought for a class action lawsuit. Schall, Brown & Schwartz LLP claims the company misled shareholders regarding the financial impact of shifting resources from its profitable Private Cloud business toward enterprise AI initiatives.
Shareholders of Hims & Hers Health are under scrutiny by litigation firm Schall, Brown & Schwartz following federal allegations that the company mishandled sensitive consumer data. The investigation centers on whether the firm misled investors by failing to disclose deceptive privacy, billing, and cancellation practices prior to a recent FTC legal action.
Investors who purchased Insulet Corporation shares between February 21, 2025, and May 26, 2026, are facing a critical deadline as a class action lawsuit moves forward. The litigation centers on allegations that the company misled the market regarding the integrity of its manufacturing processes and associated safety protocols.
Investors who held Rackspace Technology shares between May 7 and July 8, 2026, are being sought for a class action lawsuit. The legal action centers on allegations that the company misled the market by prioritizing AI growth at the expense of its stable, profitable Private Cloud business segment.
Investors who purchased Peabody Energy stock between October 14, 2024, and May 4, 2026, face an August 24 deadline to join a class action lawsuit. The litigation alleges the coal producer misled the market regarding production timelines at its Centurion mine while the site struggled with persistent operational delays.
Investors who purchased Insulet Corporation securities between February 21, 2025, and May 26, 2026, face an August 31, 2026, deadline to join a class action lawsuit. The litigation, filed by Schall Brown & Schwartz LLP, alleges the company misled the market regarding manufacturing defects and safety compliance.
Investors who purchased Peabody Energy Corporation shares between October 14, 2024, and May 4, 2026, are being urged to join a securities class action lawsuit. The litigation alleges that the company misled shareholders regarding the operational stability and growth projections of its Centurion mine project.
Futu Holdings Limited faces a class action lawsuit alleging the company misled shareholders regarding its regulatory compliance in China. The legal challenge centers on claims that the firm operated without necessary approvals from the China Securities Regulatory Commission, triggering potential violations of the Securities Exchange Act of 1934.
Investors who purchased GeneDx Holdings Corp. securities between April 16, 2025, and May 4, 2026, face an August 3, 2026, deadline to join a class action lawsuit. The litigation targets alleged violations of the Securities Exchange Act, centering on misleading financial disclosures that purportedly obscured the firm's true performance.
Investors who purchased Genius Group Limited securities between April 12, 2022, and May 30, 2025, have until August 28, 2026, to file for lead plaintiff status in a pending class action lawsuit brought by Schall Brown & Schwartz LLP.
Investors who purchased Zillow Group, Inc. stock between February 11, 2025, and May 7, 2026, face an August 10, 2026, deadline to seek lead plaintiff status in a pending securities fraud lawsuit. The litigation, filed by Schall, Brown & Schwartz LLP, targets alleged misrepresentations regarding the company’s relationship with Redfin.
Shareholders who purchased Via Transportation, Inc. stock following the company’s September 2025 initial public offering have until August 10, 2026, to seek lead plaintiff status in a pending securities fraud lawsuit. The litigation targets alleged misrepresentations regarding the firm's financial health and exposure to volatile digital asset markets.
A federal class action lawsuit now challenges ADMA Biologics, accusing the company of inflating its financial health through deceptive trade practices between August 9, 2024, and March 25, 2026. The DJS Law Group is currently organizing shareholders who incurred losses during this period to seek potential legal recovery.
Investors who held GRAIL, Inc. shares between May 13, 2025, and February 19, 2026, face an August 4 deadline to join a class action lawsuit. The litigation alleges the company misled the market by masking unfavorable results from its NHS-Galleri clinical trial while publicly promoting the study’s success.
For families navigating the transition to parenthood, the choice between traditional confinement centers and independent recovery at home often feels like a compromise. SAINT BELLA is now bridging that gap, launching a 28-day, in-home postpartum program in Irvine and Newport Beach to bring clinical and traditional support directly to the residence.
Investors who purchased Black Rock Coffee Bar stock between September 12, 2025, and May 12, 2026, face an August 17 deadline to join a securities fraud lawsuit. Schall, Brown & Schwartz LLP is currently seeking lead plaintiffs to represent shareholders in the case against the NASDAQ-listed company.
Investors who purchased ZoomInfo Technologies Inc. stock between November 3, 2025, and May 11, 2026, face an August 24, 2026, deadline to seek lead plaintiff status in a pending securities fraud lawsuit, according to the national shareholder rights firm Schall, Brown & Schwartz LLP.
PepsiCo APAC has secured a multi-year deal with Envision Energy to purchase low-carbon ammonia environmental attribute certificates, a strategic move to lower the carbon footprint of its agricultural supply chain. By decoupling environmental attributes from physical product delivery, the agreement aims to bypass logistical hurdles in decarbonizing fertilizer inputs.
Investors who held Badger Meter, Inc. stock between April 18, 2024, and April 16, 2026, face an August 3 deadline to join a class action lawsuit. The litigation, filed by Schall, Brown & Schwartz LLP, alleges the company misled shareholders regarding the true drivers of its financial performance.
Shareholders who acquired Embecta Corp. stock between November 25, 2025, and May 4, 2026, are facing a ticking clock as the DJS Law Group rallies claimants for a class action lawsuit. The litigation centers on allegations that the company misled the market regarding the stability of its pen needle business.
At the 2026 ASCO Annual Meeting, Hangzhou-based CellOrigin unveiled two advanced solid-tumor therapies while securing a strategic partnership with Walvax Biotechnology. The move signals a shift toward in vivo and multi-cell approaches, aiming to bypass the antigen heterogeneity that historically hampers T-cell treatments in aggressive cancers like ovarian and liver carcinoma.
Campbell-based NeuroRester Corp. is moving beyond passive health tracking with a new cardio-cerebral sync system designed to bridge the gap between academic research and daily routines. By compressing clinical-grade digital pulse architecture into a coin-sized wearable, the startup aims to automate sleep recovery and metabolic balance for everyday users.
With 121,483 vehicles exported in the first half of 2026, a 132% year-on-year increase, GAC Group has secured its spot on the Fortune Global 500 for the 14th consecutive year, underscoring its transition from a domestic manufacturer to a major international automotive force.
Pearson posted a strong first half for 2026, with adjusted operating profit climbing 14% to £276 million. Driven by a surge in virtual learning and strategic enterprise partnerships, the education company is maintaining its full-year guidance as it pivots to meet global demand for AI-focused workforce reskilling.
Pearson posted a solid first-half performance for 2026, delivering £276 million in adjusted operating profit—a 14% increase over the previous year. Chief Executive Omar Abbosh reaffirmed the company's full-year guidance, betting that its pivot toward AI-driven reskilling and professional certification will capture sustained global demand.